Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.

dc.contributor.authorRey, Esther
dc.contributor.authorAmpuero, Javier
dc.contributor.authorMolina-Jiménez, Francisca
dc.contributor.authorMarañón, Patricia
dc.contributor.authorGarcía-García, Yaiza
dc.contributor.authorMúñoz-Hernández, Rocío
dc.contributor.authorRomero-Gómez, Manuel
dc.contributor.authorGarcía-Monzón, Carmelo
dc.contributor.authorMajano, Pedro
dc.contributor.authorGonzález-Rodríguez, Águeda
dc.date.accessioned2025-01-07T15:43:04Z
dc.date.available2025-01-07T15:43:04Z
dc.date.issued2021
dc.identifier.doi10.1002/ctm2.275
dc.identifier.issn2001-1326
dc.identifier.pmcPMC7810262
dc.identifier.pmid33463051
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7810262/pdf
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctm2.275
dc.identifier.urihttps://hdl.handle.net/10668/27345
dc.issue.number1
dc.journal.titleClinical and translational medicine
dc.journal.titleabbreviationClin Transl Med
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Sevilla (IBIS)
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numbere275
dc.pubmedtypeLetter
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAntiviral Agents
dc.subject.meshFemale
dc.subject.meshHepatitis C
dc.subject.meshHumans
dc.subject.meshInsulin Receptor Substrate Proteins
dc.subject.meshInsulin Resistance
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshSofosbuvir
dc.subject.meshTreatment Outcome
dc.titleSofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC7810262.pdf
Size:
1.7 MB
Format:
Adobe Portable Document Format